IIPR reported total revenues of $62.9 million for Q2 2025, a 12% sequential decrease, attributed to previously disclosed tenant defaults. Adjusted funds from operations (AFFO) for the quarter was ...

The UK government recently unveiled its 10-year Life Sciences Sector Plan, putting forward a comprehensive strategy for transforming the UK into a global leader in life sciences by 2035. This ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights on AI, VC funding, and valuations.

Alexandria Real Estate Equities is a best-in-class life sciences REIT trading at a deep discount, with fundamentals intact despite sector headwinds. The current nearly 7% dividend yield and a P ...

The British government and the pharmaceutical industry remain far apart in a dispute over drug pricing that has delayed publication of a long-pending plan for the UK life sciences sector.

Achieve Life Sciences submits NDA for cytisinicline, a potential new treatment for nicotine dependence and smoking cessation.

Earlier this week, hundreds of the industry’s finest descended on the Hilton Bankside hotel in London for the inaugural Life Sciences and Research Clusters Awards, organised in partnership between ...

Based in Boston, Jed brings over 20 years of retained executive search experience, with deep expertise across the biopharmaceutical and life sciences sectors.

For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the National Health Service (NHS).

Caris Life Sciences goes public, creating a new biotech billionaire and advancing precision medicine with innovative diagnostic technology.

Caris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, David Dean ...